The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 17, 2018

Filed:

Aug. 31, 2012
Applicants:

Stephen V. Fiacco, South Pasadena, CA (US);

Terry T. Takahashi, Pasadena, CA (US);

Richard W. Roberts, South Pasadena, CA (US);

Inventors:

Stephen V. Fiacco, South Pasadena, CA (US);

Terry T. Takahashi, Pasadena, CA (US);

Richard W. Roberts, South Pasadena, CA (US);

Assignee:

University of Southern California, Los Angeles, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/06 (2006.01); G01N 33/574 (2006.01); A61K 38/28 (2006.01); A61K 49/00 (2006.01); A61K 51/08 (2006.01); C12N 5/09 (2010.01); C12Q 1/68 (2018.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01); C12N 15/67 (2006.01); A61K 47/60 (2017.01); A61K 47/55 (2017.01);
U.S. Cl.
CPC ...
C07K 7/06 (2013.01); A61K 38/28 (2013.01); A61K 47/551 (2017.08); A61K 47/60 (2017.08); A61K 49/0056 (2013.01); A61K 51/088 (2013.01); C12N 5/0693 (2013.01); C12N 15/67 (2013.01); C12Q 1/6811 (2013.01); G01N 33/5011 (2013.01); G01N 33/57415 (2013.01); G01N 33/6803 (2013.01); C12N 2501/998 (2013.01); G01N 2500/04 (2013.01); G01N 2500/10 (2013.01); G01N 2570/00 (2013.01);
Abstract

Provided herein are methods to generate and screen peptides that exhibit drug like stabilities in vitro and in vivo. By selecting for enzyme resistance, Applicants are able to derive peptides that are not only stable to a broad spectrum of proteases, but also stable to other drug processing enzymes such as cytochrome P450s. This approach provides a general method to the rapid development of highly stable peptides for therapeutic development and diagnosis. The peptides are further modified for oral bioavailability. The methods can be applied to similar peptides for the making of therapeutic compositions.


Find Patent Forward Citations

Loading…